OpGen, Inc. (Nasdaq: OPGN, "OpGen"), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that total revenue for...
Inside the top-and-worst-performing leveraged ETFs of last week.
-- Transaction unanimously supported by the boards of OpGen and Curetis and supported by debt holders
Inside the best five best leveraged ETFs of November.
These leveraged ETFs posted solid gains last week.
-- Combined company to be headquartered in Gaithersburg, MD, USA
Amsterdam, the Netherlands, San Diego, CA, USA, and Holzgerlingen, Germany, July 25, 2019, 08:00 am CEST - Curetis N.V. (the "Company" and, together with Curetis USA Inc. and Curetis GmbH, "Curetis"),...